Lauren McGuiggan

Lauren has been with Avedro, the company behind Living With KC, for over five years, where she helps drive direct to consumer marketing initiatives and digital activities. In this role, she worked to develop and execute a strategic marketing plan to bring the first and only FDA approved therapeutic treatment for progressive keratoconus to the US market in 2016. Lauren is also focused on campaigns to improve patient access to reimbursement assistance and information about FDA-approved corneal cross-linking. She graduated from Bucknell University with a BSBA degree in Management.

View Lauren's Recent Posts

BlogLauren McGuiggan
June 8, 2020

Is It Time for an Eye Exam? Here’s What You Should Know

When it comes to a timeline of when to receive an eye exam, it’s different for everyone. According to Prevent Blindness, how frequently you should be receiving exams depends on...
KC JourneysLauren McGuiggan
May 21, 2020

Keratoconus Journey: Chris H.

Chris’ life has always revolved around baseball. But when he started to have difficulty seeing, he began looking for solutions to strikeout his vision challenges.
BlogLauren McGuiggan
May 5, 2020

WJTV (Jackson): Mississippi Braves Broadcaster Chris Harris Doesn’t Let Rare Eye Disease Hold Him Back

Mississippi Braves broadcaster Chris Harris overcame keratoconus to thrive in the booth. He discusses his journey living with disease, undergoing cross-linking, and life after the procedure.
BlogLauren McGuiggan
February 24, 2020

How Rare Is Your “Rare Disease”?

In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people. Keratoconus, a progressive eye condition in which the cornea weakens and thins…

MA-00000A